Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Pharmacological modulation of CDK7 kinase activity by using THZ1 may thus provide an approach to identify and treat tumor types that are dependent on transcription for maintenance of the oncogenic state
JD-5037 is a potent CB1R antagonist with an IC50 of 1
Decreased activity and expression of the cardiac sarcoplasmic reticulum calcium ATPase (SERCA2a)
which are confirmed by the inhibition of FGFR signaling
9-cis-Retinyl Stearate-d5 Size:Contact [email protected] for quotation Pharmacological modulation of CDK7 kinaseProduct information CAS Number: 1331643 11 8 Molecular Weight: 557. 94 Formula: C38H64O2 Chemical Name: (2E,4E,6Z,8E) 3,7 dimethyl 9 [2 (H)methyl 6,6 dimethyl(3,3 H)cyclohex 1 en 1 yl]nona 2,4,6,8 tetraen 1 yl octadecanoate Smiles: [2H]C([2H])([2H])C1=C( C=C C( C)=C\C=C\C(\C)=C\COC(=O)CCCCCCCCCCCCCCCCC)C(C)(C)CCC1([2H])[2H] InChiKey: YNGACJMSLZMZOX OTZJKHJKSA N InChi: InChI=1S C38H64O2 c1 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 27 37(39)40 32 30
US$ 1279.15
US$ 368.43
US$ 545.98
US$ 2246.00
US$ 295.10
US$ 2404.10
US$ 53.95
US$ 67.10
US$ 70.95
US$ 134.47
US$ 18.85
US$ 2076.03
US$ 150.15